Press releasesRSS feed
SIStemA: A large and standardized collection of transcriptome data sets for human pluripotent stem cell research
Human pluripotent stem cells have ushered in an exciting new era for disease modeling, drug discovery, and cell therapy development. Continued progress toward realizing the potential of human pluripotent stem cells will be facilitated by robust data sets and complementary resources that are easily accessed and interrogated by the stem cell community. In this … [Read more]
CRISPR gene editing in pluripotent stem cells reveals the function of MBNL proteins during human in vitro myogenesis
Alternative splicing has emerged as a fundamental mechanism for the spatiotemporal control of development. A better understanding of how this mechanism is regulated has the potential not only to elucidate fundamental biological principles, but also to decipher pathological mechanisms implicated in diseases where normal splicing networks are mis-regulated. Here, the authors took advantage … [Read more]
What if the next generation of successful treatments was hidden in the current pharmacopoeia? Identifying new indications for existing drugs, also called the drug repurposing or drug rediscovery process, is a highly efficient and low-cost strategy. First reported almost a century ago, drug repurposing has emerged as a valuable therapeutic option for diseases that … [Read more]
AAV2/9-mediated silencing of PMP22 prevents the development of pathological features in a rat model of Charcot-Marie-Tooth disease 1 A
Charcot-Marie-Tooth disease 1 A (CMT1A) results from a duplication of the PMP22 gene in Schwann cells and a deficit of myelination in peripheral nerves. Patients with CMT1A have reduced nerve conduction velocity, muscle wasting, hand and foot deformations and foot drop walking. Here, the authors evaluate the safety and efficacy of recombinant adeno-associated viral … [Read more]
Duchenne myopathy: Myogenesis modelled by human pluripotent stem cells, a multi‐omic study of disease early onset.
We are proud to share the new publication by Virginie Mournetas and the IStem “Muscle Diseases” team: Mournetas V, et al (2021). Myogenesis modelled by human pluripotent stem cells: a multi‐omic study of Duchenne myopathy early onset. Journal of Cachexia, Sarcopenia and Muscle. doi : 10.1002/jcsm.12665 We invite you to visit … [Read more]
Doctoral student in Immunology at IStem, Élise Herardot is interested in the “reconstitution of a retina by bioengineering based on human pluripotent stem cells for the treatment of diseases affecting vision” alongside Karim Ben M’Barek and Christelle Monville. In this context, she took part in the final of Ma Thèse en 180s at … [Read more]
I-Stem research laboratory was celebrating its 10 years in cell therapy R & D last October 27th in Paris: the right time to organize a press conference gathering international top medical opinion leaders in order to make an update on their pioneering work and the major steps forward to innovative stem cell therapies. Cross funded … [Read more]
Researchers at the Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-Stem – Inserm/AFM/UEVE) have recently developed a new approach to produce different populations of motor neurons from these cells in only 14 days. Read the press release << Return to the section “Press releases”
Xavier Nissan’s research team at the Institute for Stem cell Therapy and Exploration of Monogenic Diseases (I-Stem), has identified a molecular mechanism that preserves neural cells from accelerated ageing in progeria. This work, conducted in collaboration with Nicolas Levy’s research team (Inserm/UMRS910, La Timone Faculté de Médecine, Université de la Méditerranée), was achieved by using … [Read more]
Identification of a recurrent chromosomal anomaly in neural cells derived from pluripotent stem cells (ES and iPS).
At a time when the first regenerative medicine clinical trials are being performed using pluripotent stem cells, teams from the I-Stem Institute, are continuing to explore the quality criteria that must be adopted to best ensure patient safety. Three years ago, an I-Stem team identified a genomic anomaly that very frequently appeared in undifferentiated cell … [Read more]